Literature DB >> 379337

Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women.

S Bundey, J M Crawley, J H Edwards, R A Westhead.   

Abstract

In order to obtain control values for the diagnosis of carriers of Duchenne muscular dystrophy, creatine kinase (CK) estimations were performed in two laboratories on 148 healthy teenage girls (of whom 38 were premenarchal and 110 postmenarchal), 133 healthy mature women, 124 pregnant women, and 37 postmenopausal women. These levels were highest in the premenarchal teenagers, and became successively lower in the postmenarchal teenagers, the mature women, and the pregnant women, so that the mean level of the pregnant women was less than half that of the teenagers. The CK levels then rose again after the menopause. If the distribution of CK levels in adult non-pregnant women had been taken as controls for teenagers who were possible carriers for Duchenne muscular dystrophy, then one third of those teenagers classified as carriers would have been so classified incorrectly.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 379337      PMCID: PMC1012734          DOI: 10.1136/jmg.16.2.117

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.

Authors:  K M WILSON; K A EVANS; C O CARTER
Journal:  Br Med J       Date:  1965-03-20

2.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

3.  [Carrier detection and genetic counselling in duchenne muscular dystrophy (author's transl)].

Authors:  H Moser
Journal:  Schweiz Rundsch Med Prax       Date:  1977-07-05

4.  Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.

Authors:  H Moser; J Vogt
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

5.  Pregnancy and serum-creatine-kinase levels in potential carriers of Duchenne X-linked muscular dystrophy.

Authors:  A E Emery; B King
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

6.  Pregnancy and serum C.P.K. levels in potential carriers of severe X-linked muscular dystrophy.

Authors:  H Blyth; B P Hughes
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

7.  Effect of oral contraceptive pills on the level of creatine phosphokinase with regard to carrier detection in Duchenne muscular dystrophy.

Authors:  J Simpson; H Zellweger; L F Burmeister; R Christee; M K Nielsen
Journal:  Clin Chim Acta       Date:  1974-04       Impact factor: 3.786

8.  Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.

Authors:  T B Perry; F C Fraser
Journal:  Neurology       Date:  1973-12       Impact factor: 9.910

9.  An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.

Authors:  M W Thompson; E G Murphy; P J McAlpine
Journal:  J Pediatr       Date:  1967-07       Impact factor: 4.406

10.  Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.

Authors:  M Zatz; O Frota-Pessoa; J A Levy; C A Peres
Journal:  J Genet Hum       Date:  1976-06
View more
  7 in total

1.  Race-gender differences in serum creatine kinase activity: a study among South Africans.

Authors:  R F Gledhill; C A Van der Merwe; M Greyling; M M Van Niekerk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

Review 2.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  A genetic study of Duchenne muscular dystrophy in West Midlands.

Authors:  S Bundey
Journal:  J Med Genet       Date:  1981-02       Impact factor: 6.318

4.  Clinical use of DNA markers linked to the gene for Duchenne muscular dystrophy.

Authors:  M E Pembrey; K E Davies; R M Winter; R G Elles; R Williamson; T A Fazzone; C Walker
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

5.  Prenatal deletion detection in a sporadic case of Duchenne muscular dystrophy without genotype information from the affected individual.

Authors:  F Peinemann; M Wagner; U Franke; M Kulle; J Reiss
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

Review 6.  Active Women Across the Lifespan: Nutritional Ingredients to Support Health and Wellness.

Authors:  Abbie E Smith-Ryan; Hannah E Cabre; Sam R Moore
Journal:  Sports Med       Date:  2022-09-29       Impact factor: 11.928

Review 7.  Creatine Supplementation in Women's Health: A Lifespan Perspective.

Authors:  Abbie E Smith-Ryan; Hannah E Cabre; Joan M Eckerson; Darren G Candow
Journal:  Nutrients       Date:  2021-03-08       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.